Patterns in anticoagulant utilization in the Czech Republic
during 2007-2017

J 2019

Patterns in anticoagulant utilization in the Czech Republic during 2007-2017

MALY, J., S. DVORACKOVA, E. ZIMCIKOVA, A.A. KUBENA, J. KOLAR et. al.

Základní údaje

Originální název

Patterns in anticoagulant utilization in the Czech Republic during 2007-2017

Autoři

MALY, J. (203 Česká republika), S. DVORACKOVA (203 Česká republika), E. ZIMCIKOVA (203 Česká republika), A.A. KUBENA (203 Česká republika), J. KOLAR (203 Česká republika), J. VLCEK (203 Česká republika), Miroslav PENKA (203 Česká republika, domácí) a K. MALA-LADOVA (203 Česká republika)

Vydání

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, DORDRECHT, SPRINGER, 2019, 0929-5305

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.054

Kód RIV

RIV/00216224:14110/19:00113752

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1007/s11239-019-01806-z

UT WoS

000459806100019

Klíčová slova anglicky

Anticoagulants; Drug utilization; Warfarin; DOAC; Czech Republic

Změněno: 11. 5. 2020 11:22, Mgr. Tereza Miškechová

Anotace

V originále

Direct oral anticoagulants (DOACs) have gradually entered the Czech market as alternatives to vitamin K antagonists and parenteral anticoagulants since 2008. Considering the eventual changes, the aim was to evaluate drug use and expenditure patterns on anticoagulants in the Czech Republic. A retrospective utilization study was conducted retrieving data from the State Institute for Drug Control database, including reports on drug supplies from distributors with anatomical therapeutic chemical classification (ATC) codes B01AA, B01AB, B01AE, B01AF, and B01AX. The utilization on national level was expressed as the ratio of the number of defined daily doses per 1000 inhabitants per day (DDD/TID). Expenditures on all anticoagulants were also assessed. Data was analyzed using PASW (version 18.0). Between January 2007 and December 2017, the national anticoagulant utilization rate increased continuously from 14.15 to 27.67 DDD/TID. The use of DOACs was 0.002 DDD/TID in 2008, increased to 6.04 DDD/TID in 2017. Warfarin utilization, after a small decrease in 2008, has shown nearly stable levels in the recent years (70.9% of all anticoagulants; mean 11.55 DDD/TID over the last 5years), while its increase was halted by the spread of DOACs utilization (p<0.05). In 2017, over half of the expenditures (51.1%) were due to oral anticoagulants, whereof 47.6% was related to DOACs. The results reflected a growing utilization and increasing costs of all anticoagulants, especially in DOACs at the expense of warfarin. Still, additional information regarding patient persistence and prescribing patterns is needed for a better understanding of oral anticoagulant utilization.

Citovat

MALY, J., S. DVORACKOVA, E. ZIMCIKOVA, A.A. KUBENA, J. KOLAR, J. VLCEK, Miroslav PENKA a K. MALA-LADOVA. Patterns in anticoagulant utilization in the Czech Republic during 2007-2017. JOURNAL OF THROMBOSIS AND THROMBOLYSIS. DORDRECHT: SPRINGER, 2019, roč. 47, č. 2, s. 305-311. ISSN 0929-5305. Dostupné z: https://dx.doi.org/10.1007/s11239-019-01806-z.

@article{1648898,
   author = {Maly, J. and Dvorackova, S. and Zimcikova, E. and Kubena, A.A. and Kolar, J. and Vlcek, J. and Penka, Miroslav and MalaandLadova, K.},
   article_location = {DORDRECHT},
   article_number = {2},
   doi = {http://dx.doi.org/10.1007/s11239-019-01806-z},
   keywords = {Anticoagulants; Drug utilization; Warfarin; DOAC; Czech Republic},
   language = {eng},
   issn = {0929-5305},
   journal = {JOURNAL OF THROMBOSIS AND THROMBOLYSIS},
   title = {Patterns in anticoagulant utilization in the Czech Republic during 2007-2017},
   url = {https://link.springer.com/article/10.1007%2Fs11239-019-01806-z},
   volume = {47},
   year = {2019}
}

TY  - JOUR
ID  - 1648898
AU  - Maly, J. - Dvorackova, S. - Zimcikova, E. - Kubena, A.A. - Kolar, J. - Vlcek, J. - Penka, Miroslav - Mala-Ladova, K.
PY  - 2019
TI  - Patterns in anticoagulant utilization in the Czech Republic during 2007-2017
JF  - JOURNAL OF THROMBOSIS AND THROMBOLYSIS
VL  - 47
IS  - 2
SP  - 305-311
EP  - 305-311
PB  - SPRINGER
SN  - 09295305
KW  - Anticoagulants
KW  - Drug utilization
KW  - Warfarin
KW  - DOAC
KW  - Czech Republic
UR  - https://link.springer.com/article/10.1007%2Fs11239-019-01806-z
L2  - https://link.springer.com/article/10.1007%2Fs11239-019-01806-z
N2  - Direct oral anticoagulants (DOACs) have gradually entered the Czech market as alternatives to vitamin K antagonists and parenteral anticoagulants since 2008. Considering the eventual changes, the aim was to evaluate drug use and expenditure patterns on anticoagulants in the Czech Republic. A retrospective utilization study was conducted retrieving data from the State Institute for Drug Control database, including reports on drug supplies from distributors with anatomical therapeutic chemical classification (ATC) codes B01AA, B01AB, B01AE, B01AF, and B01AX. The utilization on national level was expressed as the ratio of the number of defined daily doses per 1000 inhabitants per day (DDD/TID). Expenditures on all anticoagulants were also assessed. Data was analyzed using PASW (version 18.0). Between January 2007 and December 2017, the national anticoagulant utilization rate increased continuously from 14.15 to 27.67 DDD/TID. The use of DOACs was 0.002 DDD/TID in 2008, increased to 6.04 DDD/TID in 2017. Warfarin utilization, after a small decrease in 2008, has shown nearly stable levels in the recent years (70.9% of all anticoagulants; mean 11.55 DDD/TID over the last 5years), while its increase was halted by the spread of DOACs utilization (p<0.05). In 2017, over half of the expenditures (51.1%) were due to oral anticoagulants, whereof 47.6% was related to DOACs. The results reflected a growing utilization and increasing costs of all anticoagulants, especially in DOACs at the expense of warfarin. Still, additional information regarding patient persistence and prescribing patterns is needed for a better understanding of oral anticoagulant utilization.
ER  -

MALY, J., S. DVORACKOVA, E. ZIMCIKOVA, A.A. KUBENA, J. KOLAR, J. VLCEK, Miroslav PENKA a K. MALA-LADOVA. Patterns in anticoagulant utilization in the Czech Republic during 2007-2017. \textit{JOURNAL OF THROMBOSIS AND THROMBOLYSIS}. DORDRECHT: SPRINGER, 2019, roč.~47, č.~2, s.~305-311. ISSN~0929-5305. Dostupné z: https://dx.doi.org/10.1007/s11239-019-01806-z.

Podrobný výpis o publikaci